Publication:
Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue

dc.contributor.authorStosic-Grujicic, S. (7004253020)
dc.contributor.authorMaksimovic-Ivanic, D. (6507584634)
dc.contributor.authorMiljkovic, D. (7006524033)
dc.contributor.authorTrajkovic, V. (7004516866)
dc.contributor.authorLukic, M. (7005792112)
dc.contributor.authorMostarica Stojkovic, M. (6701741422)
dc.date.accessioned2025-06-13T00:47:20Z
dc.date.available2025-06-13T00:47:20Z
dc.date.issued2002
dc.description.abstract[No abstract available]
dc.identifier.urihttps://doi.org/10.1016/S0041-1345(02)03502-9
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0036844325&doi=10.1016%2fS0041-1345%2802%2903502-9&partnerID=40&md5=d22507f9d074b42891e8f474c0528fb7
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/11252
dc.titleInhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue
dspace.entity.typePublication

Files